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Abstract
Background: Leaves and root bark of Fraxinus xanthoxyloides Wall. (Oleaceae) are used locally for the treatment of
jaundice, malaria and pneumonia. Decoction of stem, twigs and bark is used in pain, internal injuries, rheumatism
and in bone fracture. In this investigation we have evaluated the methanol extract of leaves for its hepatoprotective
potential against CCl4 induced hepatic injuries in rat.
Methods: Powder of F. xanthoxyloides leaves was extracted with methanol (FXM) and subjected for the
determination of polyphenolics through HPLC-DAD analysis. Sprague–Dawley (Rattus novergicus) male rats were
divided into eight groups (six rats in each). Group I: non-treated control; Group II: vehicle treated (DMSO plus olive
oil) while Group III- VI treated with 1 ml/kg body weight (bw) of CCl4 (30 % in olive oil) for 30 days (15 dosages) to
induce the hepatic injuries. Group IV: treated with silymarin (100 mg/kg bw); Group V and VI with FXM (200,
400 mg/kg bw) on alternate days with CCl4 treatment. Group VII and VIII was administered with FXM (200, 400 mg/
kg bw) alone (15 dosages). After 30 days the serum was evaluated for liver function enzymes and biochemical
markers, liver samples for antioxidant enzymes, biochemical markers, comet assay and for histopathology.
Results: HPLC-DAD analysis of FXM revealed the existence of rutin and caffeic acid. In CCl4 treated rats the level of
alanine transaminase (ALT), aspartate transaminase (AST), total bilirubin was significantly increased while the albumin
concentration in serum was decreased as compared to control group. The level of hepatic antioxidant enzymes, catalase
(CAT), peroxidase (POD), superoxide dismutase (SOD), glutathione-S-transferase (GST) and glutathione reductase (GSR) was
significantly decreased against the control group. Further, significant decrease in GSH while increase in lipid peroxides
(TBARS), H2O2, DNA damages and comet length was induced with CCl4 in hepatic tissues of rat. In contrast, co-
administration of FXM and silymarin restored the biochemical and histopathological status of the liver.
Conclusion: Results of present investigation revealed that F. xanthoxyloides leaves possibly protect the liver against CCl4
induced injuries like silymarin by its antioxidant constituents.
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Background
Plants are used traditionally for the treatment and pre-
vention of several human diseases and are thought to
play their undeniable role in health care system. In living
systems free radicals such as superoxide anion (O2•-),
hydroxyl radicals (OH•), singlet oxygen (1O2) and other
reactive oxygen species like hydrogen peroxide (H2O2)
are known to play their deleterious role and have
damaging effects on different cellular organelles. These
are supposed to be the main cause of pathogenesis of
different human diseases like cancer, atherosclerosis, dia-
betes mellitus, arthritis, Alzheimer’s disease and Parkin-
sonism. High concentrations of ROS within the cell
leads to destruction and disruption of lipids of the mem-
branous system, cellular proteins and causes DNA dam-
age thus causes several diseases [1, 2].
Antioxidants are the compounds capable of preventing
or reducing harmful effects of free radicals. The exogen-
ous antioxidants mainly consist of synthetic and natural
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antioxidants. Treatment of different diseases using ex-
ogenous antioxidants is of prime importance but due to
side effects of synthetic antioxidants their use is limited.
There have been increasing safety concerns over syn-
thetic antioxidants. For example, butylated hydroxyani-
sole (BHA) and butylated hydroxytoluene (BHT), the
two well-known synthetic antioxidants, have been re-
stricted for their DNA damaging and other toxic effects
[3]. Moreover it has been also determined that natural
antioxidants of vegetables and fruits prevent different
diseases [4].
Hepatic diseases are the most common of all the path-
ologies worldwide and constitute up to 83 % of all the
cases. Among the hepatic pathologies toxicity is the
most common risk factor which is usually contributed
by food additives, alcohol, toxic industrial chemicals, air
and water pollutants. Carbon tetrachloride (CCl4) is a
toxin used in animal models that mimics the oxidative
stress led injuries in various organs [5, 6]. It is metabo-
lized by cytochrome P-450, and produces trichloro-
methyl (CCl3) radical and chlorine. Trichloromethyl
radical has the capacity to abstract double allylic hydro-
gen atoms from polyenoic fatty acids of cellular mem-
branes. This reaction led to the generation of
chloroform and highly reactive secondary lipid radicals
that react with molecular oxygen to form lipid peroxy
radicals. Alternatively the trichloromethyl radical directly
reacts with the molecular oxygen to form the peroxytri-
chloromethyl radical (CCl3O2) that is even more injuri-
ous to that of trichloromethyl radical in the production
of lipid peroxy radicals. These lipid peroxydized fatty
acids eventually decomposed in to stable carbonyls such
as malondialdehyde pentane and ethane [7]. On the
other hand trichloromethyl radical can bind with macro-
molecules and causes massive damages to proteins,
DNA and lipids. So CCl4 elicits the generation of unsat-
urated fatty acids, lipoperoxides and free radicals that
contribute to the pathological consequences [8].
Treatment of oxidative stress induced pathologies with
natural antioxidants is of great concern these days. Daily
intake of green leafy vegetables, fresh fruits and tea
(Camellia sinensis) as a source of natural antioxidants
have been found useful for prevention of cardiovascular
and neurodegenerative diseases [6, 9, 10]. Among phyto-
chemicals flavonoids are the most prominent for their
antioxidant action. Quenching of free radicals is a prop-
erty of flavonoids imparted by their redox property as a
result they act as reducing agents, singlet oxygen scaven-
gers, hydrogen donors and reductants of ferryl
hemoglobin [11]. Plants possessing flavonoids exhibit
strong anti-inflammatory, antiviral, antioxidant, anti-
allergenic, anti-fungal, anti-bacterial, anticancer, cyto-
toxic and hepatoprotective activities thus, generated
curiosity about flavonoid containing plants [12–14].
Fraxinus xanthoxyloides (Wall. ex G.Don) DC. (Family
Oleaceae) is found in Northern areas of Pakistan,
Afghanistan, India, Morocco and in Algeria. It is com-
monly known as Afghan ash. Local practitioners in
northern areas of Pakistan use its leaves and root bark
for the treatment of jaundice, malaria and pneumonia
[15]. Stem bark of F. xanthoxyloides is used in the form
of decoction by the local communities to reduce pain
during labor [16], expulsion of pre-mature infant after
death [17] and also used in traumas [18]. Decoction of
stem/twigs is also used in wounds and bone fractures in
cattle [19]. Its wood is used by the local people in bone
fracture [20]. Its leaves are also used as fodder [15]. Use
of the extract of F. excelsior seeds in diabetic volunteers
had significantly reduced the postprandial rise in gly-
cemia while enhanced the insulin secretion [21]. Treat-
ment of obese mice with extracts of F. excelsior seeds
limited the gain in weight and hyperglycemia [22]. Fur-
ther, seed extract of F. excelsior protected the micronu-
clei in irradiated human lymphocytes and did not induce
changes in hematological and biochemical parameters
after 90 days of its use in human [23]. Administration of
10 mg/kg of methanol extract of the aerial parts of F.
micrantha produced significant anti-inflammatory ef-
fects against carrageenan-induced acute inflammation in
mice [24]. Xanthoxyloidin, a new biscoumarin together
with esculetin, 5,7- dihydroxycoumarin and 6,8-dihy-
droxy-7-methoxycoumarin were isolated from the
methanol extract of the whole plant of F. xanthoxyloides
[25]. Intraperitoneal administration of stem bark extract
of F. ornus displayed anti-inflammatory activity in both
zymosan- and carrageenan-induced paw edema in mice
[26]. Significant anti-nociceptive and anti-inflammatory
activities of the methanol extract at 200 and 400 mg/kg
doses of Fraxinus floribunda leaves have been reported
[27]. The ethanol extract of the aerial parts of F. rhynch-
ophylla attenuated the liver fibrosis induced with CCl4
in rat probably through free radical scavenging abilities
[28]. Streptozotocin and paracetamol induced diabetes
and the liver injuries have been attenuated by the treat-
ment of leaves and stem bark extract of F. angustifolia in
mice. Treatment of mice with both extracts had dimin-
ished the lipid peroxidation and increase in biochemical
markers of serum in streptozotocin and paracetamol in-
duced damages in mice. The results suggest that hepato-
protective and antidiabetic proficiencies might have been
established by the presence of antioxidant constituents
in the plant [29]. In vitro antioxidant activities of the
various aqueous extracts from the bark of F. floribunda
have also been reported [30]. Antioxidant capabilities of
the extracts from leaves and stem bark of F. angustifolia
have also been appraised through in vitro studies [31].
Moulaoui et al. [32] also investigated the wound healing
potential of F. angustifolia. Inner stem bark of F.
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micrantha has been used by the local communities of
Dharchula, India for liver enlargement, jaundice and
other liver disorders [33]. Liver diseases such as jaun-
dice, enlargement, fibrosis are usually induced by oxida-
tive stress and inflammatory processes [1, 2]. Based on
the studies reported earlier for the use of Fraxinus spe-
cies in liver and anti-inflammatory disorders it was spec-
ulated that the traditional use of F. xanthoxyloides in
jaundice by the local communities of Pakistan might be
attributed through the antioxidant abilities of the phyto-
constituents. In this perspective that natural antioxidant
play a role in hepato-protection, the present study was
undertaken to evaluate the methanol extract of F.
xanthoxyloides leaves for its hepato-protective properties
against the CCl4 induced hepatic toxicity in rat. For the
purpose biomarkers of serum, liver homogenate and
histopathology was investigated. Further, HPLC-DAD




The leaves of F. xanthoxyloides were collected in Octo-
ber, 2013 from the campus of Quaid-i-Azam University
Islamabad, Pakistan. The plant was recognized by its
local name and then validated by Dr. Rizwana Aleem
Qureshi, Department of Plant Sciences, Quaid-i-Azam
University Islamabad. Specimen was (45679) submitted
to National Herbarium, Quaid-i-Azam University,
Islamabad, Pakistan.
Preparation of crude extract and fractions
After collection, plant samples were shade dried and
powdered by using grinder. Powder (1 kg dry weight)
was soaked in 4 l of 95 % crude methanol for 72 h and
repeated the above procedure twice. For the purpose of
filtration, Whatman No. 1 filter was used and methanol
was evaporated on a rotary evaporator at 40 °C under re-
duced pressure. Extract (FXM) was stored at 4 °C for
further investigation.
High performance liquid chromatography (HPLC) analysis
Presence of polyphenolic components of the FXM was
detected by the HPLC-DAD analysis. The apparatus
used was of Agilent Germany and analytical column was
of Sorbex RXC8 (Agilent USA) with 5 μm particle size
and 25 ml capacity. Mobile phase consisted of eluent A,
(acetonitrile-methanol–water-acetic acid /5: 10: 85: 1)
and eluent B (acetonitrile-methanol-acetic acid/40: 60:
1). The gradient (A: B) utilized was the following: 0–
20 min (0 to 50 % B), 20–25 min (50 to 100 % B), and
then isocratic 100 % B (25–40 min) at flow rate of 1 ml/
min. The injection volume of the sample was 20 μl. Be-
fore injection the samples were filtered through 0.45 μm
membrane filter. Among the standards rutin and gallic
acid were analyzed at 257 nm, catechin at 279 nm, caf-
feic acid at 325 nm and quercetin, myricetin, kaempferol
were analyzed at 368 nm. Every time column was recon-
ditioned for 10 min before the next analysis. All samples
were assayed in triplicate. Quantification was carried out
by the integration of the peak using the external stand-
ard method. All chromatographic operations were car-
ried out at an ambient temperature.
Animal studies
CCl4 induced hepatic injuries
Protective effects of FXM on the CCl4 induced liver in-
juries were evaluated on healthy male Sprague Dawley
(150–200 g) (Rattus novergicus) rats with mean age of
2 months. Experimental animals (48) were randomly di-
vided into eight groups having six rats in each. The ani-
mals were placed in conventional steel cages at room
temperature with 12 h light and dark cycle at the Pri-
mate Facility of Quaid-i-Azam University, Islamabad.
The experimental protocol (Bch#271) for the use of ani-
mal was approved by the ethical board of Quaid-i-Azam
University, Islamabad. Animals were fed on rodent chow
and tap water ad libitum. Protocol of Shyu et al. [34]
was followed to carry out this experiment. Animals of
Group I were remained untreated (control), Group II as
vehicle control (1 ml/kg bw; 10 % DMSO in olive oil, or-
ally). Rats of Group III - VI were administered CCl4
(1 ml/kg bw; 30 % CCl4 in olive oil) orally on alternative
days for 30 days (15 dosages). Group IV was also treated
with silymarin (100 mg/kg bw) while Group V and VI
with FXM (200, 400 mg/kg bw) on alternate days with
CCl4 treatment (15 dosages, orally). FXM alone (200,
400 mg/kg bw) was administered to Group VII and
Group VIII for 30 days (15 dosages). The dosages of
FXM to rats were based on the studies reported earlier
[35]. All the treatments were carried out in the morning.
Before dissection, all rats were kept on normal feed
without any treatment for at least 24 h. Rats were eutha-
nized after ether anesthesia. By using 23 G1 syringes,
cardiac puncture was done and blood samples were col-
lected in falcon tubes. Falcon tubes were centrifuged at
500 × g for 15 min at 4 °C and sera were collected for
biochemical analysis. Liver was dissected out, rinsed
with ice cold saline to remove debris. A part of liver
after drying in liquid nitrogen was stored at −70 °C for
tissue homogenate tests. Small part of organs was stored
in 10 % phosphate buffered formalin for comet assay
and histopathological studies.
Serum analysis
For the analysis of serum samples of rats, the diagnostics
kits of AMP (Krenngasse 12, 8010 Graz, Australia) were
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used to estimate AST, ALT, total bilirubin, albumin and
globulin level in serum samples.
Antioxidant enzymes assessment
An amount of 100 mg of hepatic tissue of each animal
was homogenized in 1 ml of potassium phosphate buffer
(100 mM) containing EDTA (1 mM) at pH 7.4. The cen-
trifugation of homogenate was done at 12,000 × g at 4 °C
for 30 min to obtain the supernatant for following anti-
oxidant enzyme assays.
Catalase (CAT) activity
For the CAT activity determination, the protocol of
Chance and Maehly [36] was followed. The CAT reac-
tion solution consisted of 625 μl of 50 mM of potassium
phosphate buffer (pH 5), 100 μl of 5.9 mM H2O2 and
35 μl of the supernatant. After one minute, changes in
absorbance of the reaction mixture at 240 nm were re-
corded. One unit of catalase activity was stated as an ab-
sorbance change of 0.01 as units/min.
Peroxidase (POD) activity
Activity of POD was assayed by Chance and Maehly [36]
protocol with slight modifications. POD reaction solu-
tion contained 75 μl of 40 mM hydrogen peroxide, 25 μl
of 20 mM guaiacol, 625 μl of 50 mM potassium phos-
phate buffer (pH 5.0) and 25 μl of supernatant. After an
interval of one minute, change in absorbance was deter-
mined at 470 nm. One unit POD activity is equivalent to
change in absorbance of 0.01 as units/min.
Superoxide dismutase (SOD) activity
Activity level of SOD was estimated by the protocol of
Kakkar et al. [37]. By using phenazine methosulphate
and sodium pyrophosphate buffer SOD activity was
assessed. Centrifugation of tissue homogenate was done
at 1500 × g for 10 min and then at 10,000 × g for 15 min.
Supernatant was collected and 150 μl of it was added to
the aliquot containing 600 μl of 0.052 mM sodium pyro-
phosphate buffer (pH 7.0) and 50 μl of 186 mM of phen-
azine methosulphate. In the end to initiate enzymatic
reaction, 100 μl of 780 μM NADH was added. After
1 min, glacial acetic acid (500 μl) was added to stop the
reaction. At 560 nm absorbance was determined to enu-
merate the color intensity. Results were evaluated in
units/mg protein.
Glutathione-S-transferase (GST) activity
Protocol of Habig et al. [38] was followed for the estima-
tion of GST activity. The assay was based on formation
of 1-chloro-2,4-dinitrobenzene (CDNB) conjugate. A
volume of 150 μl of tissue supernatant was added to
720 μl of sodium phosphate buffer together with 100 μl
of reduced glutathione (1 mM) and 12.5 μl of CDNB
(1 mM). By spectrophotometer, absorbance was re-
corded at 340 nm. Through molar coefficient of 9.61 ×
103/M/cm, GST activity was determined as amount of
CDNB conjugate formed per minute per mg protein.
Glutathione reductase (GSR) activity
The glutathione reductase activity in the hepatic tissues
was assessed by the method of Carlberg and Mannervik
[39]. GSR activity was based on the conversion of oxi-
dized glutathione (GSSG) into reduced glutathione
(GSH) at the expense of NADPH. Briefly, 50 μl of liver
supernatant was added to a reaction mixture consisting
of 25 μl of 1 mM oxidized glutathione (GSSG), 50 μl of
0.5 mM EDTA and 825 μl of 0.1 M sodium phosphate
buffer (pH 7.6). Then an aliquot of 50 μl of 0.1 mM
NADPH was added to the reaction mixture to initiate
the process and decline in absorbance was recorded at
340 nm at 25 °C for 20 min. Using molar extinction co-
efficient of 6.22 × 103/M/cm, GSR activity was assessed
as amount of NADPH oxidized/min/mg protein.
Estimation of biochemical parameters
Reduced glutathione (GSH) estimation
Quantity of GSH in liver tissues was assessed following
the protocol of Jollow et al. [40]. Precipitation of tissue
homogenate (500 μl) was carried out by the addition of
(500 μl) 4 % sulfosalicylic acid. After 1 h of incubation at
4 °C the reaction mixture was centrifuged for 20 min at
1200 × g. An aliquot of 33 μl of the supernatant was
added to 900 μl of 0.1 M potassium phosphate buffer
(pH 7.4) and 66 μl of 100 mM of 5,5′-dithio-bis(2-nitro-
benzoic acid (DTNB). Reaction of GSH with DTNB pro-
duced a yellow colored derivative 5′-thio-2-nitrobenzoic
acid (TNB). The absorbance of the reaction mixture was
recorded at 412 nm. The GSH activity was expressed as
μmole GSH/g tissue.
Lipid peroxidation assay (TBARS)
Protocol of Iqbal et al. [41] was adopted with slight
modifications for the assessment of lipid peroxidation.
The reaction mixture consisted of 290 μl of 0.1 M phos-
phate buffer (pH 7.4), 10 μl of 100 mM ferric chloride,
100 μl of 100 mM ascorbic acid, and 100 μl of homoge-
nized sample. After 1 h incubation of the mixture at 37 °
C in shaking water bath, 500 μl of trichloroacetic acid
(10 %) was added to inhibit the reaction. Then 500 μl of
0.67 % thiobarbituric acid was added and the reaction
tubes were placed in water bath for 20 min. After that
the tubes were placed in crushed ice bath for 5 min and
centrifugation was done at 2500 × g for 12–15 min. Ab-
sorbance of the supernatant was recorded at 535 nm. By
using molar extinction coefficient of 1.56 × 105 /M/cm,
results were calculated as nmole of TBARS formed per
min per mg tissue at 37 °C.
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Protein assessment
Procedure of Lowry et al. [42] was followed in order to
find the total soluble proteins within the tissues. For this
purpose, 100 mg of organ was weighed and
homogenization was done in potassium phosphate buf-
fer. Homogenized mixture was centrifuged at 4 °C at
10,000 × g for 15–20 min to obtain the supernatant. Al-
kaline solution 1 ml was added in 0.1 ml of supernatant
and mixed vigilantly with the help of vortex machine.
Then the incubation was done for 30 min. Afterwards
the change in absorbance was calculated at 595 nm. Bo-
vine serum albumin (BSA) curve was used to find out
the concentration of serum proteins in the sample.
Hydrogen peroxide assay
Estimation of hydrogen peroxide was done by following
Pick and Keisari [43] protocol. The H2O2 horseradish
peroxidase enzyme brought about the oxidation of phe-
nol red. In the reaction mixture, 500 μl of 0.05 M phos-
phate buffer (pH 7),100 μl of homogenate was added
along with 100 μl of 0.28 nmole phenol red solution,
250 μl of 5.5 nmole dextrose and horse radish peroxid-
ase (8.5 units) was added. Incubation was done at room
temperature for 60 min. A volume of 100 μl of NaOH
(10 N) was added to stop the reaction. Then mixture
tubes were centrifuged for 5–10 min at 800 × g. By spec-
trophotometer the absorbance of the collected super-
natant was measured against reagent as a blank at
610 nm. Production of H2O2 was measured as nmole
H2O2/min/mg tissue on the basis of standard curve of
H2O2 oxidized phenol red.
DNA injuries
Comet assay
We have adopted the protocol of Dhawan et al. [44] to
monitor the DNA damages through comet assay. Steril-
ized slides were dipped in hot normal melting agarose
(1 %) solution and allowed to solidify at room
temperature. A small piece of liver tissue was placed in
1 ml of cold lysing solution and minced in to small
pieces and mixed with 75 μl of low melting agarose solu-
tion. This mixture was coated on the already coated
slides and a cover slip was gently placed over it. The
slide was placed on ice packs for about 8–10 min. Cover
slip was removed and again low melting point agarose
was added and placed on ice packs for solidification.
After three coating with low melting point agarose slide
was again placed in the lysing solution for about 10 min
and placed in refrigerator for 2 h. After electrophoresis
slide was stained with 1 % ethidium bromide and visual-
ized under fluorescent microscope. CASP 1.2.3.b image
analysis software was used to evaluate the extent of
DNA damage. In each sample 50–100 cells were
analyzed for comet length, head length, tail length, tail
moment and DNA content in head of renal cell’s nuclei.
DNA fragmentation assay
Protocol of Wu et al. [45] was adopted for the estima-
tion of DNA injuries in hepatic tissues of rat. A volume
of 0.1 ml of the hepatic tissues homogenate in Tris tri-
ton EDTA (TTE) labelled B was centrifuged at 200 × g at
48 °C for 10 min. The supernatant collected was labelled
S and again centrifuged at 20,000 × g for 10 min at 48 °
C. The intact chromatin obtained was labeled C. After
addition of 1.0 ml of 25 % TCA to all tubes; B, S and C
were incubated overnight at 48 °C. After centrifugation
at 18,000 × g at 48 °C the precipitated DNA was recov-
ered. To each tube 160 ml of 5 % TCA was added and
heated for 15 min at 90 °C followed by the addition of
320 ml of freshly prepared DPA solution. Each tube was
vortexed vigorously and incubated for 4 h at 37 °C. Op-
tical density of the reaction assay was recorded at
600 nm. The results were presented as %fragmented
DNA by using the formula:




For histopathological examination, a fixative containing
absolute alcohol (85 ml), glacial acetic acid (5 ml) and
40 % formaldehyde (10 ml) was used to fix hepatic tis-
sues. For slides preparation, thin sections of fresh tissues
of liver about 3–4 μm were used. The hematoxylin-eosin
stain was used for staining purpose and for histopatho-
logical study a light microscope (DIALUX 20 EB) at
magnification of 40X was used.
Statistical analysis
The values were expressed as mean ± standard deviation.
For in vivo studies, the consequences of different treat-
ments given to animals were evaluated by one way ana-
lysis of variance which was carried by means of
computer software GraphPad prism 4.0. Multiple com-
parisons among various treatments were made by
Tukeys’ HSD method at P-value ≤ 0.01.
Results
HPLC-DAD analysis
Qualitative analysis of the crude methanol extract of F.
xanthoxyloides leaves was carried out by using HPLC-
DAD and their chromatographic profile was compared
with the retention times and absorption spectrum of ref-
erence standards (rutin, kaempferol, myricetin, gallic
acid, catechins, caffeic acid and quercetin). From the
HPLC profile it was observed that FXM contains rutin
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26.13 ± 1.2 μg/mg and caffeic acid 29.22 ± 2.8 μg/mg of
extract (Fig. 1).
Effect of FXM on serum markers
The results obtained for the treatment of CCl4 and with
co-administration of FXM on the serum biochemical
markers are shown in Table 1. Treatment of CCl4 signifi-
cantly (P < 0.001) increased the level of liver function en-
zymes; AST and ALT as compared to the control group.
Multiple comparison among the treatments indicated
that the increase in the level of liver function enzymes
with CCl4 was significantly decreased with the co-
administration of silymarin as well as with the both
doses of FXM. The activity level of AST and ALT re-
corded with co-administration of silymarin and the
higher dose of FXM (400 mg/kg) was statistically similar
to each other. However, administration of FXM alone at
both the doses did not induce any significant (P > 0.05)
change in the serum level of AST and ALT as compared
with the control group.
In this experiment serum level of total bilirubin was
significantly (P < 0.001) increased with CCl4 treatment as
compared to the control group. The toxicity induced
with CCl4 was ameliorated by the co-administration of
silymarin and also at both doses of FXM. On the other
hand serum level of total bilirubin was decreased dras-
tically (P < 0.01) at higher dose of FXM (400 mg/kg) and
did not differ from the control group. Serum level of the
total bilirubin of the groups treated with FXM alone
(200, 400 mg/kg) remained statistically (P > 0.05) similar
with the control group.
In animals treated with CCl4 the level of albumin was
decreased (P < 0.001) whereas the level of globulin was
increased (P < 0.001) as compared to the control group.
Co-administration of silymarin and the two doses of
FXM attenuated the CCl4 intoxication and the level of
the albumin and the globulin in serum was restored to-
wards the control level. Multiple comparisons of the
treatments exhibited that the level of albumin and
globulin in serum of silymarin and FXM (both doses)
treated groups was statistically (P > 0.01) similar among
each other and also with control group. Co-
administration of silymarin produced more marked
ameliorating effects on the toxicity induced with CCl4
and the level of globulin in serum did not differ from
the control group. However, the level of globulin ob-
tained with co-administration of FXM was significantly
lower to that of the control group. The results indicated
that the treatment of FXM alone did not induce signifi-
cant (P > 0.05) changes in the albumin and the globulin
as compared to the control group.
Effect of FXM on antioxidant enzymes of liver
Table 2 indicates significant (P < 0.001) decrease in the
activity level of antioxidant enzymes of liver; CAT, POD,
SOD, GST and GSR as compared to the control group.
Prophylactic treatment of FXM and silymarin reduced
the toxicity of CCl4 and the activity level of hepatic anti-
oxidant enzymes was restored towards the control
group. Multiple comparisons of various treatments indi-
cated that low dose of FXM (200 mg/kg) was not much
effective in ameliorating the oxidative stress induced
Fig. 1 HPLC-DAD profile of the crude methanol extract of F. xanthoxyloides (FXM)
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with CCl4 so that the activity level of all the hepatic anti-
oxidant enzymes evaluated in this experiment showed
lower activity to that of the control group. The activity
level of antioxidant enzymes was significantly (P < 0.01)
restored by the co-administration of the higher dose of
FXM (400 mg/kg) and with silymarin. However, treat-
ment of FXM alone at both the doses; 200 and 400 mg/
kg alone did not alter the level of these parameters as
compared to the control.
Effect of FXM on biochemical markers of liver
The toxic effects of CCl4 and the protective potential of
FXM on the biochemical parameters of liver are pre-
sented in Table 3. Treatment of CCl4 increased the con-
centration of lipid peroxides (TBARS), H2O2 and DNA
injuries while decreased (P < 0.001) the protein and GSH
content in the liver tissues as compared to the control
group. Co-administration of FXM at its both level of
dosages decreased the content of TBARS, H2O2 and
DNA injuries as compared to the CCl4 group. Protein
and GSH concentration in the hepatic tissues was also
increased by the co-treatment of FXM (at both doses)
and with silymarin. Multiple comparison among differ-
ent treatments indicated that restoration potential of
FXM (400 mg/kg) and silymarin on TBARS, H2O2 and
the GSH content towards the control was statistically
similar to each other. Administration of FXM (both
doses) alone did not induce alteration (P > 0.05) in the
concentration of the above biochemical markers of liver
as compared to the control group.
Effect of FXM on comet parameters
Table 4 shows the protective effects of FXM on the comet
parameters after toxicity induced with CCl4 in hepatic cells
of rat. The results obtained in this study indicated that the
treatment of CCl4 induced the DNA injuries in hepatic cells
and the comet length, head length, tail length, %DNA in tail
and the tail moment was significantly (P < 0.001) increased
as compared to the control group. However, %DNA in head
was significantly (P < 0.001) decreased as against the control
group. Prophylactic treatment of FXM alleviated the toxic
effects of CCl4 and reversed the above parameters towards
the control group. Multiple comparison among various
treatments indicated that higher dose of FXM (400 mg/kg)
significantly (P < 0.01) restored all the parameters of comet
and its protective effects were comparable to the silymarin
treatment. Administration of FXM alone did not alter
Table 1 Effect of FXM on biochemical parameters of serum in rat
Treatment AST (U/l) ALT (U/l) Bilirubin (mg/dl) Albumin (mg/dl) Globulin (mg/dl)
Control 86.66 ± 5.35d 32.66 ± 4.17 d 0.165 ± 0.024c 4.45 ± 0.27a 1.55 ± 0.18c
DMSO + Olive oil 89.50 ± 6.05 d 33.16 ± 3.65 d 0.160 ± 0.025c 4.60 ± 0.17a 1.52 ± 0.18bc
CCl4 319.83 ± 20.22
†a 204.67 ± 20.91†a 0.663 ± 0.132†a 2.33 ± 0.31†b 2.27 ± 0.10†a
CCl4 + silymarin (100 mg/kg) 122.00 ± 21.07
≠c 63.50 ± 5.28†c 0.256 ± 0.043*bc 3.93 ± 0.21a 1.81 ± 0.26bc
CCl4 + FXM (200 mg/kg) 212.67 ± 29.04
†b 105.50 ± 6.53†b 0.325 ± 0.030†b 4.00 ± 0.50a 2.13 ± 0.09†ab
CCl4 + FXM (400 mg/kg) 116.83 ± 12.25
*cd 61.33 ± 6.21†c 0.161 ± 0.030c 4.23 ± 0.47a 2.09 ± 0.23†ab
FXM (200 mg/kg) 84.83 ± 5.07 d 36.66 ± 3.66 d 0.156 ± 0.021c 4.35 ± 0.18a 1.51 ± 0.14c
FXM (400 mg/kg) 86.66 ± 4.88 d 33.16 ± 3.06 d 0.161 ± 0.023c 4.43 ± 0.32a 1.60 ± 0.14c
FXM F. xanthoxyloides methanol extract. Data values shown represent mean ± SD (n = 6). One way analysis of variance was followed by Dunnet comparison of
various treatments with control at: *, P < 0.05; #, P < 0.01; ǂ, P < 0.001. Multiple comparisons among treatments were determined by Tukeys’ HSD test. Superscript
alphabets indicate significance among treatments (P < 0.01) on not sharing common letter
Table 2 Effect of FXM on antioxidant enzymes of liver in rat
Treatment CAT (U/min) POD (U/min) SOD (U/mg protein) GST (mM/min/mg protein) GSR (mM//min/mg protein)
Control 3.88 ± 0.53ab 9.55 ± 0.99ab 3.00 ± 0.31a 160.81 ± 8.53a 224.62 ± 9.02a
DMSO + Olive oil 4.19 ± 0.27a 10.65 ± 1.44ab 3.07 ± 0.27a 158.56 ± 11.67a 220.11 ± 8.01a
CCl4 2.33 ± 0.18
†c 5.31 ± 0.63†c 1.30 ± 0.23†c 100.11 ± 4.99†c 130.52 ± 9.77†d
CCl4 + silymarin (100 mg/kg) 3.88 ± 0.28
ab 9.31 ± 0.67ab 2.93 ± 0.23ab 151.02 ± 9.49ab 180.88 ± 9.17†c
CCl4 + FXM (200 mg/kg) 2.64 ± 0.15
†c 7.45 ± 0.39†b 1.58 ± 0.11†c 133.85 ± 8.34†b 184.83 ± 8.90†c
CCl4 + FXM (400 mg/kg) 3.37 ± 0.24
*b 9.01 ± 0.55ab 2.46 ± 0.19≠b 150.70 ± 8.98ab 198.03 ± 10.64†bc
FXM (200 mg/kg) 3.79 ± 0.23ab 9.44 ± 0.87ab 2.99 ± 0.18a 159.57 ± 9.57a 221.17 ± 7.15a
FXM (400 mg/kg) 3.91 ± 0.45ab 9.59 ± 0.75ab 2.94 ± 0.20ab 159.66 ± 9.63a 216.03 ± 8.42ab
FXM F. xanthoxyloides methanol extract. Data values shown represent mean ± SD (n = 6). One way analysis of variance was followed by Dunnet comparison of
various treatments with control at: *, P < 0.05; #, P < 0.01; ǂ, P < 0.001. Multiple comparisons among treatments were determined by Tukeys’ HSD test. Superscript
alphabets indicate significance among treatments (P < 0.01) on not sharing common letter
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(P > 0.05) the level of comet parameters as compared
to the control group (Fig. 2).
Effect of FXM on histopathology of liver
Histopathology of the hematoxylin and eosin stained
sections of hepatic tissues is presented in Fig. 3. Typical
normal histology of liver parenchyma cells, sinusoids
and central vein in untreated control and vehicle treated
groups (Fig. 3a, b) was observed. Administration of CCl4
for 30 days caused severe liver injuries, marked in-
creased in fatty changes, cellular hypertrophy, and nec-
rotic foci, degeneration of the lobular architecture,
macrosteatosis and congested blood vessels with dis-
turbed epithelium (Fig. 3c). Co-administration of sily-
marin ameliorated the hepatic injuries and decreased the
collagen deposition with very less or no fatty changes
and maintained normal lobular architecture near to con-
trol group (Fig. 3d). Treatment of 200 mg/kg of FXM
along with CCl4 represented hepatic injuries (Fig. 3e).
However, the higher dose of FXM exhibited the hepato-
protective potential near to control group (Fig. 3f ). The
histological observations are supporting the serological
findings as well as biochemical studies in respect of
oxidative stress. The administration of FXM alone did
not induce histopathological alteration in liver tissues
(Fig. 3g, h).
Discussion
Foods rich in polyphenolics especially flavonoids are
considered important nutraceuticals having health pro-
moting effects in human. As flavonoids impart many
medicinal properties, but perhaps the most important
are the scavenging and chelating effects on free radicals.
The HPLC analysis of FXM has indicated the presence
of two flavonoids; rutin and caffeic acid. Rutin (quer-
cetin-3-rhamnosyl glucoside), a natural flavone deriva-
tive exhibited several biological activities; antioxidant,
antimicrobial, antiallergic, anti-inflammatory, vasoactive,
antitumor [46–48]. Rutin has convincingly ameliorated
the toxic effects of CCl4 and has shown the hepato and
nephroprotective abilities [49, 50]. It was investigated
that the expression of CYP2E1 in liver cells of rat was
decreased by the administration of CCl4 to rats. How-
ever, the level of CYP2E1 was not affected by the treat-
ment of CCl4 metabolites such as trichloromethyl and
trichloromethyl peroxy radicals. The decrease in the











Control 2.98 ± 0.13a 21.05 ± 2.18abc 2.96 ± 0.28d 2.49 ± 0.09c 2.51 ± 0.15d
DMSO + Olive oil 2.98 ± 0.09a 21.35 ± 2.16ab 3.24 ± 0.36d 2.60 ± 0.19bc 2.58 ± 0.15d
CCl4 1.05 ± 0.14
†c 11.38 ± 0.93†e 6.19 ± 0.65†a 3.99 ± 0.33†a 6.22 ± 0.63†a
CCl4 + silymarin (100 mg/
kg)
2.81 ± 0.10a 17.87 ± 1.01≠bcd 4.20 ± 0.27†bc 2.93 ± 0.20*bc 2.94 ± 0.21cd
CCl4 + FXM (200 mg/kg) 1.87 ± 0.13
†b 14.62 ± 1.56d†e 4.65 ± 0.47†b 3.04 ± 0.25≠b 4.50 ± 0.34†b
CCl4 + FXM (400 mg/kg) 2.91 ± 0.11
a 17.73 ± 1.00≠cd 3.80 ± 0.34≠cd 2.74 ± 0.35bc 3.38 ± 0.23†c
FXM (200 mg/kg) 2.90 ± 0.13a 21.74 ± 1.82a 2.95 ± 0.19d 2.51 ± 0.21c 2.55 ± 0.09d
FXM (400 mg/kg) 2.89 ± 0.11a 22.35 ± 1.65a 3.13 ± 0.33d 2.49 ± 0.18c 2.49 ± 0.16d
FXM F. xanthoxyloides methanol extract. Data values shown represent mean ± SD (n = 6). One way analysis of variance was followed by Dunnet comparison of
various treatments with control at: *, P < 0.05; #, P < 0.01; ǂ, P < 0.001. Multiple comparisons among treatments were determined by Tukeys’ HSD test. Superscript
alphabets indicate significance among treatments (P < 0.01) on not sharing common letter
Table 4 Effect of FXM on comet parameters of liver cells in rat
Treatment Comet length (μm) Head length (μm) Tail length (μm) DNA head (%) DNA tail (%) Tail moment (μm)
Control 33.26 ± 1.17d 26.55 ± 1.14c 6.71 ± 1.85d 96.81 ± 0.94a 3.18 ± 0.94d 0.51 ± 0.02c
DMSO + Olive oil 33.16 ± 1.03d 26.27 ± 0.36c 6.88 ± 1.29d 96.89 ± 1.00a 3.10 ± 1.00d 0.52 ± 0.01c
CCl4 65.21 ± 1.74
ǂa 42.01 ± 2.02ǂa 23.20 ± 2.56ǂa 70.00 ± 1.54ǂd 29.99 ± 1.54ǂa 1.80 ± 0.10ǂa
CCl4 + silymarin (100 mg/kg) 40.79 ± 1.67
ǂc 28.71 ± 1.01*c 12.07 ± 1.56ǂbc 89.81 ± 1.13ǂb 10.18 ± 1.13ǂc 0.60 ± 0.03≠bc
CCl4 + FXM (200 mg/kg) 49.25 ± 2.32
ǂb 33.29 ± 1.19ǂb 15.96 ± 3.25ǂb 85.86 ± 1.68ǂc 14.14 ± 1.68ǂb 0.68 ± 0.02ǂb
CCl4 + FXM (400 mg/kg) 40.98 ± 1.68
ǂc 26.86 ± 1.08c 14.11 ± 1.56ǂb 90.65 ± 1.32ǂb 9.35 ± 1.32ǂc 0.60 ± 0.02≠bc
FXM (200 mg/kg) 33.93 ± 1.60d 26.22 ± 0.99c 7.71 ± 2.44cd 94.74 ± 2.23a 5.25 ± 2.23d 0.53 ± 0.01c
FXM (400 mg/kg) 34.32 ± 1.33d 26.43 ± 1.41c 7.88 ± 1.60cd 95.37 ± 1.03a 4.62 ± 1.03d 0.53 ± 0.01c
FXM F. xanthoxyloides methanol extract. Data values shown represent mean ± SD (n = 6). One way analysis of variance was followed by Dunnet comparison of
various treatments with control at: *, P < 0.05; #, P < 0.01; ǂ, P < 0.001. Multiple comparisons among treatments were determined by Tukeys’ HSD test. Superscript
alphabets indicate significance among treatments (P < 0.01) on not sharing common letter
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Fig. 2 Comet studies of hepatic tissues. Ethidium bromide stain; 40× (a) Untreated control (b) vehicle treated (DMSO + olive oil) (c) CCl4 treated
(d) CCl4 + silymarin (100 mg/kg) treated (e) CCl4 + FXM (200 mg/kg) treated (f) CCl4 + FXM (400 mg/kg) treated (g) FXM (200 mg/kg) treated (h)
FXM (400 mg/kg) treated rats. FXM; F. xanthoxyloides leaves methanol extract
Fig. 3 Histopathological studies of liver. Hematoxylin and eosin stain; 40× (a) Untreated control showing normal histoarchitecture of the hepatic
tissues (b) vehicle treated (DMSO + olive oil) showing normal histoarchitecture of the hepatic tissues (c) CCl4 treated showing macrosteatosis (d)
CCl4 + silymarin (100 mg/kg) treated showing almost normal histoarchitecture (e) CCl4 + FXM (200 mg/kg) treated showing microsteatosis (f) CCl4
+ FXM (400 mg/kg) treated showing mild microsteatosis (g) FXM (200 mg/kg) treated showing normal histoarchitecture of the hepatic tissues (h)
FXM (400 mg/kg) treated showing normal histoarchitecture of the hepatic tissues of rat. FXM; F. xanthoxyloides leaves methanol extract
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expression level of CYP2E1 might occur through the
production of active metabolites of CCl4 by an inde-
pendent CYP2E1 pathway [51]. The downregulation of
CYP2E1 might account the over expression of inflamma-
tory mediators. The decrease in CYP2E1 expression in-
duced with CCl4 in liver of rat was restored with the
administration of rutin [50]. Caffeic acid reduces the
acute immune and inflammatory response [51]. Caffeic
acid also possesses antitumor abilities [52]. It has also
been illustrated that these compounds are strong antiox-
idants, in which caffeic acid is considered to be the high-
est antioxidant due to the dihydroxylation of 3, 4-
position on the phenolic ring of caffeic acid [53]. Fur-
ther, the HPLC-DAD analysis revealed the existence of
other phenolic compounds as well (Fig. 1). FXM and its
derived fractions exhibited anti-inflammatory activities
both in vitro and in vivo studies by lowering the concen-
tration of inflammatory mediators including nitric oxide.
GC-MS analysis of FXM indicated the presence of squa-
lene, 2-linoleoyl glycerol, 2-palmitoyl glycerol anti-
inflammatory compounds which prevent activation of
macrophages, neutrophils and monocytes [35]. Liver is
directly affected by the release of CCl4 metabolites and
cytokines that propagate inflammatory response [54].
Antioxidant capacity of FXM in this study might be at-
tributed by the existence of rutin, caffeic acid and other
antioxidant and/or anti-inflammatory compounds in
protecting the biological system against the potentially
harmful effects of free radicals.
Three pure compounds; rutin and nummularic acid
from ethyl acetate fraction and plectranthoic acid from
chloroform fraction of FXM were isolated and character-
ized by NMR and other spectroscopic analyses (data not
shown). Nummularic acid and plectranthoic acid are the
triterpenoids, a class of phyto-chemicals. Use of plec-
tranthoic acid during in vitro studies has 5'AMP-acti-
vated kinase (AMPK) activity that is considered to be a
metabolic hub for the treatment of type-2 diabetes and
cancer [55]. Further GC-MS analysis of the FXM indi-
cated the presence of various compounds belonging to
15 major classes of which; three were terpenoids
(26.61 %), four lactam (16.47 %), three esters (15.81 %),
three phenols (8.37 %), two steroid (6.91 %), three alco-
hols (5.02 %), three ketones (4.49 %), one aldehyde
(3.89 %), two fatty acid glycerol (3.01 %), one nitrile
(2.64 %), two lactones (2.31 %), one silyl-ether (2.25 %),
one alkene (1.31 %) and one alkyne (0.89 %) [35].
Jaundice is also included among the inflammatory dis-
eases induced with free radicals. ROS are recognized as
the main factors involved in DNA damages, lipid peroxi-
dation and protein injuries. Liver is highly vulnerable to
chemical toxicity and liver cirrhosis as one of the domin-
ant processes that lead towards the death of the organ-
ism. A number of studies have indicated that liver
damages can be induced in experimental organisms by
administration of CCl4. Metabolites of CCl4 namely tri-
chloromethyl and trichloromethyl peroxy radicals are
produced during its metabolism by cytochrome P-450,
and imposes oxidative stress that cause widespread liver
damages. Leaves of F. xanthoxyloides are used locally in
the treatment of various disorders including jaundice
[15].
Recent studies have indicated the potential therapeutic
importance of plant derived products against the oxida-
tive stress induced hepatic anomalies [12, 56]. Estima-
tion of the liver function enzymes; AST and ALT, total
bilirubin, albumin and globulin represent the quantita-
tive marker of the hepatocellular damage and the meta-
bolic integrity of the liver. In this experiment the
increased level of AST, ALT, total bilirubin and globulin
while deceased level of albumin in serum indicated the
severe hepatocellular damages induced with CCl4 intoxi-
cation. The enzymes; AST and ALT are cytoplasmic in
location and the significant increase in the level of AST
and ALT in serum of CCl4 treated group might occur as
leakage or necrosis of the hepatic cells reflecting lipid
peroxidation of cellular membranes. Severe hepatic dam-
ages induced with CCl4 intoxication depressed the func-
tion of liver. Significant increase in globulin while the
decrease in albumin indicated the extensive damages in-
duced with CCl4 that led to the reduced synthesis of al-
bumin. Decrease in albumin can also be accounted due
to enhanced proteinuria as reported in various studies
[57, 58]. However, prophylactic treatment of FXM re-
stored the liver function enzymes, total bilirubin, albu-
min and globulin in serum. These results suggested the
therapeutic role of FXM against the oxidative damages.
The restoration of the above parameters might occur
due to prevention of oxidative injuries and stabilization
of the cellular membranes [59].
In this experiment activity level of antioxidant en-
zymes; CAT, POD, SOD, GST and GSR of hepatic tissues
was significantly decreased indicating that the oxidative
stress was induced with the treatment of CCl4 in rat. It
is an accepted view that the coordinated action of anti-
oxidant enzymes is a prerequisite for scavenging of dele-
terious free radicals. The overwhelming and perpetual
generation of free radicals suppresses the activities of
antioxidant enzymes. The superoxide radicals generated
during the normal metabolism and/or during intoxica-
tion are converted by the SOD enzyme in to H2O2
which is subsequently decomposed by CAT and glutathi-
one peroxidase thus eliminating the potential hazardous
effect of hydroxyl radicals to the tissues. In this investi-
gation the treatment of CCl4 to rats elevated the concen-
tration of H2O2 in hepatic tissues. The severe hepatic
injuries observed in this experiment with CCl4 provide a
link that OH radicals generated during the conversion of
Younis et al. BMC Complementary and Alternative Medicine  (2016) 16:407 Page 10 of 13
H2O2 can abstract hydrogen from the poly unsaturated
fatty acid of the membranous system. Further, the com-
promised activity of antioxidant enzymes deteriorates
the situation by generation of secondary free radicals.
The results presented in this study are instigated with
other studies [59, 60] where the CCl4 intoxication has
increased the level of H2O2 and suppressed the activity
of antioxidant enzymes in hepatic tissues. The rats ex-
posed to CCl4 and with FXM simultaneously exhibited
significant increase in the activity level of antioxidant en-
zymes along with significant decrease in H2O2 of sample
homogenates as compared to the CCl4 group. These re-
sults support the proposed mechanism that CCl4 in-
duces oxidative stress in hepatic tissues by generation of
free radicals whereas the co-administration of FXM alle-
viates the oxidative stress by scavenging of free radicals
and led to the restoration of antioxidant enzymes. These
resulted have been supported by other studies where the
co-administration of antioxidant agents have ameliorated
the toxic effects of CCl4 and brought back the activity
level of antioxidant enzymes [60].
In the present studies the toxicity of CCl4 led to a sig-
nificant increase in lipid peroxides (TBARS) while sig-
nificant decrease in GSH in liver homogenate samples as
compared to the control group. Treatment of CCl4 in-
duces oxidative stress in hepatic tissues by generation of
free radicals and is implicated in lipid peroxidation [60].
Estimation of lipid peroxides in the sample is an effect-
ive approach to verify the presence of hepatic anomalies.
Restoration of TBARS in hepatic samples by co-
administration of FXM in this study indicated the pro-
tective potential against the CCl4 induced hepatic injur-
ies in rat. These results have been verified by obtaining
lower damages during histopathological studies. GSH
plays a crucial role during scavenging of free radicals es-
pecially during the decomposition of H2O2 and scaven-
ging of hydroxyl radicals. CCl4 provoked free radicals
are detoxified by forming conjugates with GSH and this
property of GSH render it to play a major role in elimin-
ation of CCl4 induced toxic metabolites. The availability
of GSH dispensed the maintenance of oxidants and its
depletion may result in severe hepatic injuries. In this
study treatment of FXM restores the concentration of
GSH that provides a plausible mechanism of hepato-
protection against oxidative injuries [59, 60].
Lipid peroxidation is a dual process not only involved
in the destruction of membranous system of the cell but
is also involved in the synthesis of highly reactive hydro
peroxides having enormous ability to interact with pro-
teins and even DNA. The enhanced level of DNA injur-
ies in hepatic tissues was recorded with the treatment of
CCl4 to rats. The results obtained in this study are in
line to a previous study where the DNA fragmentation
and the major oxidative lesion 8-oxo-2-deoxyguanosine
(oxo8dG) were increased in liver with CCl4 treatment
and reverted towards the control level with co-
administration of rutin to rats [49]. Oxo8dG in DNA in-
duces misreading during DNA synthesis in vitro and
leads to G→T transversion mutagenesis. Studies of
comet assays of the hepatic cells have endorsed the
DNA injuries induced with CCl4 metabolites. There has
been an increase in the comet length, head and tail
length and %DNA in tail in cells of liver samples. The
increase in these parameters might reflect the DNA
breaks and the damages of the membranous system of
the hepatic cells. Such injuries might augment the hep-
atic injuries and functional anomalies. The results re-
corded in this study were in conformity to Sajid et al.
[61] where the comet length had increased while the
%DNA in head was decreased with CCl4 treatment to
rats. However a restoration in these comet parameters
was recorded with co-administration of methanol extract
of Artemisia scoparia [61].
Conclusion
The altered biological profile of hepatic tissues induced
with CCl4 was restored towards the control level by the
co-administration of FXM and silymarin, a standard
antioxidant drug to rats. These results suggested the
repairing as well as regenerative capacity of the antioxi-
dants present in FXM.
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